Ocuphire Pharma, Inc. (OCUP) Financials

OCUP Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 53.9 million 4.0 million
2023-09-30 54.2 million 3.9 million
2023-06-30 43.5 million 5.8 million
2023-03-31 45.4 million 4.2 million

OCUP Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 4.5 million 711000
2023-09-30 -3.0 million 573000
2023-06-30 989000 1.4 million
2023-03-31 -3.6 million 804000

OCUP Net Income

No data available :(

OCUP Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 50.5 million - -
2023-09-30 42.4 million - -
2023-06-30 40.0 million - -
2023-03-31 39.0 million - -

OCUP Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 23.0 million
2023-09-30 22.4 million
2023-06-30 21.0 million
2023-03-31 20.9 million

OCUP Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 - 3.8 million 3.3 million -
2023-09-30 - 3.5 million 2.1 million -
2023-06-30 - 4.7 million 4.3 million -
2023-03-31 - 5.6 million 2.3 million -

OCUP Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 1.7 million 3000
2023-09-30 11.9 million 1000
2023-06-30 3.7 million 1000
2023-03-31 1.7 million 1000

OCUP

Price: $1.61

52 week price:
1.51
6.60

Earnings Per Share: -0.46 USD

P/E Ratio: 1.75

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 340500

Market Capitalization: 47.4 million

Links: